Related Experiment Video
Updated: May 12, 2026
08:26
Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
Published on: October 19, 2015
Targeting intracellular compartments by magnetic polymeric nanoparticles
Petra Kocbek1, Slavko Kralj, Mateja Erdani Kreft
1Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia. kocbekp@ffa.uni-lj.si
Summary
Ricinoleic acid-coated maghemite nanoparticles were synthesized and incorporated into a polymeric matrix, creating magnetic polymeric nanoparticles (MNPs). These MNPs show superparamagnetic properties and can be internalized by breast cancer cells, with potential for targeted delivery, though internalization is low.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Materials Chemistry
Background:
- Superparamagnetic iron oxide nanoparticles (SPIONs) offer potential for bioapplications like drug targeting and imaging due to their magnetic properties.
- Bare iron oxide nanoparticles may exhibit toxicity; surface coating is crucial to mitigate direct interactions with biological systems.
- Developing safe and effective magnetic nanocarriers is essential for advanced biomedical applications.
Purpose of the Study:
- To synthesize and characterize ricinoleic acid-coated maghemite nanoparticles incorporated into a polymeric matrix.
- To evaluate the superparamagnetic properties and cellular uptake of the developed magnetic polymeric nanoparticles (MNPs).
- To assess the biocompatibility and potential cytotoxicity of the MNPs on T47-D breast cancer cells.
Main Methods:
- Synthesis of ricinoleic acid-coated maghemite nanoparticles and their incorporation into a polymeric matrix.
- Characterization of superparamagnetic properties and response to an external magnetic field.
- Bioevaluation using T47-D breast cancer cells, including internalization studies (fluorescent and transmission electron microscopy) and cytotoxicity assays (metabolic activity, cell cycle analysis, scanning electron microscopy).
Main Results:
- Nanosized magnetic polymeric particles with superparamagnetic properties were successfully synthesized.
- MNPs were internalized by T47-D cells and localized in subcellular compartments, influenced by an external magnetic field.
- Low internalization rates suggest suitability for highly potent drug delivery; MNPs affected cell adhesion and plasma membrane integrity but showed reversible effects on metabolic activity and normal cell cycle distribution at tested concentrations.
Conclusions:
- The developed magnetic polymeric nanoparticles are safe for T47-D breast cancer cells at tested concentrations, exhibiting reversible effects on cellular functions.
- The magnetic responsiveness and internalization capability of MNPs indicate potential for targeted drug delivery applications.
- Further optimization is needed to enhance MNP internalization for broader therapeutic applications.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.